Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics
|
April 30, 2026
Evaluating Oxaliplatin Exposure in Adults with Advanced Colorectal Cancer: Development and Validation of Methods with Enhanced Bioanalytical Specificity and Clinical Applicability
John Ho, Catherine Han, Mark James McKeage
Journal of Diabetes Science and Technology
|
March 18, 2023
Vacuum-Assisted Needle-Free Capillary Blood Sampling
Michael Hoffman, James McKeage, Bryan Ruddy, et al.
The Lancet Regional Health. Western Pacific
|
July 14, 2022
Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study
Alice Minhinnick, Phyu Sin Aye, J Mark Elwood, et al.
Plos One
|
May 7, 2021
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
Phyu Sin Aye, Mark James McKeage, Sandar Tin Tin, et al.
Cancer Epidemiology
|
October 30, 2020
Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status
Phyu Sin Aye, Mark James McKeage, Sandar Tin Tin, et al.
BMC Cancer
|
July 16, 2020
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand
Phyu Sin Aye, Sandar Tin Tin, Mark James McKeage, et al.
Journal of Dentistry
|
May 17, 2022
Jet injection needle-free dental anaesthesia: Initial findings
Paul A Brunton, Mitten McLean, Senthilkumar Vedagiri, et al.
JMIR Research Protocols
|
July 2, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy
Phyu Sin Aye, Joanne Barnes, George Laking, et al.
JMIR Cancer
|
March 3, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study
Phyu Sin Aye, Joanne Barnes, George Laking, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
European Journal of Drug Metabolism and Pharmacokinetics
|
April 30, 2026
Evaluating Oxaliplatin Exposure in Adults with Advanced Colorectal Cancer: Development and Validation of Methods with Enhanced Bioanalytical Specificity and Clinical Applicability
John Ho, Catherine Han, Mark James McKeage
Journal of Diabetes Science and Technology
|
March 18, 2023
Vacuum-Assisted Needle-Free Capillary Blood Sampling
Michael Hoffman, James McKeage, Bryan Ruddy, et al.
The Lancet Regional Health. Western Pacific
|
July 14, 2022
Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study
Alice Minhinnick, Phyu Sin Aye, J Mark Elwood, et al.
Plos One
|
May 7, 2021
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
Phyu Sin Aye, Mark James McKeage, Sandar Tin Tin, et al.
Cancer Epidemiology
|
October 30, 2020
Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status
Phyu Sin Aye, Mark James McKeage, Sandar Tin Tin, et al.
BMC Cancer
|
July 16, 2020
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand
Phyu Sin Aye, Sandar Tin Tin, Mark James McKeage, et al.
Journal of Dentistry
|
May 17, 2022
Jet injection needle-free dental anaesthesia: Initial findings
Paul A Brunton, Mitten McLean, Senthilkumar Vedagiri, et al.
JMIR Research Protocols
|
July 2, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy
Phyu Sin Aye, Joanne Barnes, George Laking, et al.
JMIR Cancer
|
March 3, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study
Phyu Sin Aye, Joanne Barnes, George Laking, et al.
Page
of 1